Home | News | Find a Doctor | Ask a Question | Free

Could histogen potentially release a soluable before the injectable?


#1

Is this feasible? Could they release a soluable formula of HSC without putting it through a ton of trials?


#2

» Is this feasible? Could they release a soluable formula of HSC without
» putting it through a ton of trials?

Soluble* forgive my spelling…


#3

Looks like the WNT molecule is much too large for trans-dermal delivery…unless of course they come up with some new novel delivery topically.

As a side note, I can see this forum went to hell. Always nice to see fellow hair loss suffers acting civil trying to help each other out…wtf!!!


#4

If they release their stuff in any way, shape, or form, then it won’t be long before someone distills out the additives and injects it with a syringe like the HM trials are doing.


#5

@GoGiants:
why do you assume that a topical formulation wouldn’t need to undergo clinical trials?

» If they release their stuff in any way, shape, or form, then it won’t be
» long before someone distills out the additives and injects it with a
» syringe like the HM trials are doing.


#6

» @GoGiants:
» why do you assume that a topical formulation wouldn’t need to undergo
» clinical trials?
»
» » If they release their stuff in any way, shape, or form, then it won’t
» be
» » long before someone distills out the additives and injects it with a
» » syringe like the HM trials are doing.

I wasn’t assuming, I was wondering. I’m pretty uneducated on the manner and on the conduct of scientific trials, thank you guys for the response though.


#7

Wrong thread


#8

I remember reading something about how Histogen were planning on testing some kind of topical, this is what I found looking for it.

Histogen plans to begin two additional pilot trials of HSC as a topical treatment (with no injections below the skin) in the United States over the next six months. Dr. Craig Ziering, a Southern California hair transplant surgeon, will oversee the tests. Ziering, an osteopath who has offices in Beverly Hills, Newport Beach, La Jolla, Las Vegas, NV, and Salt Lake City, UT, also sits on Histogen’s scientific advisory board. Naughton says one of the studies will apply HSC to transplanted hair follicles and is intended to test its suitability in preventing hair loss. The other U.S. study calls for applying HSC on scar tissue from previous hair transplant procedures.

I don’t know if they started those trials or not.